Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 1;25(6):110831.
doi: 10.15446/rsap.V25n6.110831. eCollection 2023 Dec.

[Hypertension-abdominal obesity phenotype as an indicator of dysglycaemia and insulin resistance]

[Article in Spanish]
Eduardo Cabrera-Rode  1 , Brayam Javier Loaiza-Romero  2 , Janet Rodríguez-Acosta  3 , Ileana Cubas-Dueñas  4 , José Hernández-Rodríguez  5 , Oscar Díaz-Díaz  6
Affiliations

[Hypertension-abdominal obesity phenotype as an indicator of dysglycaemia and insulin resistance]

[Article in Spanish]
Eduardo Cabrera-Rode et al. Rev Salud Publica (Bogota). .

Abstract
in English, Spanish

Objective: To determine the usefulness of the hypertension-abdominal obesity phenotype as an indicator of dysglycaemia and insulin resistance.

Materials and methods: Cross-sectional descriptive study of 964 adults (449 women and 515 men) who attended the Institute of Endocrinology with risk of diabetes mellitus. Demographic (age, sex, skin colour), clinical (blood pressure and acanthosis nigricans), anthropometric (weight, height, waist circumference and body mass index) and laboratory (basal and oral glucose tolerance test-stimulated blood glucose and insulinaemia) variables were analysed. The insulin resistance index was calculated. The abdominal hypertension-obesity phenotype was defined as the presence of systolic pressure ≥130 mm Hg and/or diastolic pressure ≥80 mm Hg or treated hypertension, waist circumference ≥80 cm in women and ≥90 cm in men. Sensitivity, specificity and predictive values of the abdominal obesity hypertension phenotype were calculated to identify dysglycaemia and insulin resistance.

Results: Individuals with the hypertension-abdominal obesity phenotype showed a higher proportion of impaired glucose metabolism and insulin resistance than those without the phenotype (p<0.0001). The hypertension-abdominal obesity phenotype better identifies persons with the presence of double prediabetes, diabetes mellitus and insulin resistance, as they show high sensitivities (85.9%, 77.5%, and 68.9%, respectively), and high negatives predictive values (97.9%, 95.8%, and 74.0%, respectively).

Conclusions: The hypertension-abdominal obesity phenotype is a simple, useful option for identifying persons with dysglycaemia, and insulin resistance.

Objetivo: Determinar la utilidad del fenotipo hipertensión-obesidad abdominal como indicador de disglucemia y resistencia a la insulina.

Material y Métodos: Estudio descriptivo transversal con 964 personas adultas (449 mujeres y 515 hombres), que asistieron al Instituto de Endocrinología con riesgo de diabetes mellitus. Se analizaron variables demográficas (edad, sexo, color de la piel), clínicas (tensión arterial y Acantosis nigricans), antropométricas (peso, talla, circunferencia de la cintura e índice de masa corporal) y de laboratorio (glucemia basal y estimulada con la prueba de tolerancia a la glucosa oral e insulinemia). Se calculó el índice de resistencia a la insulina. El fenotipo hipertensión-obesidad abdominal se definió como la presencia de presión sistólica ≥130 mm Hg o presión diastólica ≥80 mm Hg o hipertensión arterial tratada, circunferencia de cintura ≥80 cm en mujeres y ≥90 cm en hombres. Se calculó la sensibilidad, la especificidad y los valores predictivos del fenotipo hipertensión obesidad abdominal para identificar disglucemia y resistencia a la insulina.

Resultados: Los individuos con el fenotipo hipertensión-obesidad abdominal mostraron mayor proporción de alteraciones del metabolismo de la glucosa y de resistencia a la insulina que las personas sin el fenotipo (p<0,0001). El fenotipo hipertensión-obesidad abdominal identifica mejor a personas con presencia de prediabetes doble, diabetes mellitus y resistencia a la insulina, pues muestran sensibilidades altas (85,9%, 77,5%, y 68,9%, respectivamente) y valores predictivos negativos altos (97,9%, 95,8%, y 74,0%, respectivamente).

Conclusiones: El fenotipo hipertensión-obesidad abdominal es una opción sencilla, útil para identificar a personas con disglucemia y resistencia a la insulina.

Keywords: Abdominal obesity; diabetes mellitus; dysglycaemia; hypertension; insulin resistance (source: MeSH, NLM); prediabetes.

PubMed Disclaimer

Conflict of interest statement

Conflictos de intereses: Ninguno.

References

    1. Müller TD, Blüher M, Tschbp MH, DiMarchi RD. Anti-obesity drug disco-very: advances and challenges. Nat Rev Drug Discov. 2022;21(3):201–223. doi: 10.1038/s41573-021-00337-8. - DOI - PMC - PubMed
    1. Zhang P, Sun X, Jin H, Zhang F-L, Guo Z-N, Yang Y. Association be-tween obesity type and common vascular and metabolic diseases: A cross-sectional study. Front Endocrinol (Lausanne) 2019;10:900–900. doi: 10.3389/fendo.2019.00900. - DOI - PMC - PubMed
    1. Oussaada SM, van Galen KA, Cooiman MI, Kleinendorst L, Hazebroek EJ, van Haelst MM, et al. The pathogenesis of obesity. Metabolism. 2019;92:26–36. doi: 10.1016/j.metabol.2018.12.012. - DOI - PubMed
    1. Choi D, Choi S, Son JS, Oh SW, Park SM. Impact of discrepancies in general and abdominal obesity on major adverse cardiac events. J Am Heart Assoc. 2019;8(18):e013471. https://do.org/10.1161/JAHA.119.013471 - DOI - PMC - PubMed
    1. Wang Y, Howard AG, Adair LS, Wang H, Avery CL, Gordon-Larsen P. Waist circumference change is associated with blood pressure change independent of BMI change. Obesity (Silver Spring) 2020;28(1):146–153. doi: 10.1002/oby.22638. - DOI - PMC - PubMed

Publication types